We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Diabetes May Lead to Precursor of Alzheimer's

By HospiMedica staff writers
Posted on 23 Apr 2007
Adults with diabetes may be at higher risk for developing mild cognitive impairment, a condition that is often seen as a precursor to Alzheimer's disease, a new study has found.

Researchers at Columbia University (New York, NY, USA) looked at 918 men and women older than 65 (average age 75.9) who did not have mild cognitive impairment or dementia at the start of the study. More...
The participants were assessed every 18 months with an in-person interview as well as physical and neurological examinations. Almost one-quarter (23.9%) of the participants had diabetes, 68.2% had high blood pressure, 33.9% had heart disease, and 15% had suffered a stroke. During follow-up that averaged 6.1 years, 334 of the participants developed mild cognitive impairment.

The results of the study showed that people with diabetes had a higher risk of having mild cognitive impairment (MCI), especially amnestic MCI, which affects memory more than non-amnestic MCI. Overall, 8.8% of cases of MCI among the study participants could be attributable to diabetes. Rates were higher for black Americans (8.4%) and Hispanics (11%) than for non-Hispanic whites (4.6 %). These figures are consistent with the higher prevalence of diabetes among minority populations in the United States. The researchers speculated that one explanation for the link could be that diabetes could contribute to plaque build-up in the brain, a hallmark of Alzheimer's disease. The study was published in the April 2007 issue of Archives of Neurology.

"There is mounting evidence that diabetes is bad for cognition,” said lead author Dr. Jose A. Luchsinger, an assistant professor of medicine at Columbia University. "The mechanisms need to be elucidated. Type 2, or adult-onset diabetes, which the study refers to, is increasing in the U.S. and in the world. The consequences of the potential cognitive complications of diabetes could be devastating from a public health standpoint.”


Related Links:
Columbia University

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Emergency Ventilator
Shangrila935
Pressure Guidewire
SavvyWire
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.